Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism.

American journal of blood research

Paciaroni K, Lucarelli G, Martelli F, Migliaccio AR, von Lindern M, Borg J, Gillemans N, van Dijk TB, Philipsen S.
PMID: 25232502
Am J Blood Res. 2014 Sep 05;4(1):27-32. eCollection 2014.

Currently, bone marrow transplantation is the only curative treatment for β-thalassemia and sickle cell disease. In rare cases, sustained and full fetal hemoglobin production was observed in patients after failure of bone marrow transplantation. This rendered the patients transfusion-free,...

Cite
Paciaroni K, Lucarelli G, Martelli F, et al. Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism. Am J Blood Res. 2014;4(1):27-32
Paciaroni, K., Lucarelli, G., Martelli, F., Migliaccio, A. R., von Lindern, M., Borg, J., Gillemans, N., van Dijk, T. B., & Philipsen, S. (2014). Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism. American journal of blood research, 4(1), 27-32.
Paciaroni, Katia, et al. "Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism." American journal of blood research vol. 4,1 (2014): 27-32.
Paciaroni K, Lucarelli G, Martelli F, Migliaccio AR, von Lindern M, Borg J, Gillemans N, van Dijk TB, Philipsen S. Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism. Am J Blood Res. 2014 Sep 05;4(1):27-32. eCollection 2014. PMID: 25232502; PMCID: PMC4165118.
Copy Download .nbib Format: NLM
Getting personal with B19 parvovirus.

Blood

Migliaccio G, Migliaccio AR.
PMID: 20133475
Blood. 2010 Feb 04;115(5):922-3. doi: 10.1182/blood-2009-11-252593.

No abstract available.

Cite
Migliaccio G, Migliaccio AR. Getting personal with B19 parvovirus. Blood. 2010;115(5):922-3doi: 10.1182/blood-2009-11-252593.
Migliaccio, G., & Migliaccio, A. R. (2010). Getting personal with B19 parvovirus. Blood, 115(5), 922-3. https://doi.org/10.1182/blood-2009-11-252593
Migliaccio, Giovanni, and Migliaccio, Anna Rita. "Getting personal with B19 parvovirus." Blood vol. 115,5 (2010): 922-3. doi: https://doi.org/10.1182/blood-2009-11-252593
Migliaccio G, Migliaccio AR. Getting personal with B19 parvovirus. Blood. 2010 Feb 04;115(5):922-3. doi: 10.1182/blood-2009-11-252593. PMID: 20133475.
Copy Download .nbib Format: NLM
The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.

American journal of blood research

Varricchio L, Migliaccio AR.
PMID: 25755906
Am J Blood Res. 2014 Dec 15;4(2):53-72. eCollection 2014.

Glucocorticoids are endogenous steroid hormones that regulate several biological functions including proliferation, differentiation and apoptosis in numerous cell types in response to stress. Synthetic glucocorticoids, such as dexamethasone (Dex) are used to treat a variety of diseases ranging from...

Cite
Varricchio L, Migliaccio AR. The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis. Am J Blood Res. 2014;4(2):53-72
Varricchio, L., & Migliaccio, A. R. (2014). The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis. American journal of blood research, 4(2), 53-72.
Varricchio, Lilian, and Migliaccio, Anna Rita. "The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis." American journal of blood research vol. 4,2 (2014): 53-72.
Varricchio L, Migliaccio AR. The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis. Am J Blood Res. 2014 Dec 15;4(2):53-72. eCollection 2014. PMID: 25755906; PMCID: PMC4348794.
Copy Download .nbib Format: NLM
Stem cell-derived erythrocytes as upcoming players in blood transfusion.

ISBT science series

Migliaccio AR.
PMID: 26229549
ISBT Sci Ser. 2013 Jun;8(1):165-171. doi: 10.1111/voxs.12048.

BACKGROUND: Blood transfusion is current standard-of-care for genetic forms of anemia that would be otherwise lethal and allows implementation of aggressive cytotoxic/surgical therapies developed for numerous types of cancer. In developed countries the blood supply is adequate and sporadically...

Cite
Migliaccio AR. Stem cell-derived erythrocytes as upcoming players in blood transfusion. ISBT Sci Ser. 2013;8(1):165-171doi: 10.1111/voxs.12048.
Migliaccio, A. R. (2013). Stem cell-derived erythrocytes as upcoming players in blood transfusion. ISBT science series, 8(1), 165-171. https://doi.org/10.1111/voxs.12048
Migliaccio, A R. "Stem cell-derived erythrocytes as upcoming players in blood transfusion." ISBT science series vol. 8,1 (2013): 165-171. doi: https://doi.org/10.1111/voxs.12048
Migliaccio AR. Stem cell-derived erythrocytes as upcoming players in blood transfusion. ISBT Sci Ser. 2013 Jun;8(1):165-171. doi: 10.1111/voxs.12048. PMID: 26229549; PMCID: PMC4517842.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries